2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Synthesis, Photochemical and In Vitro Cytotoxic Evaluation of New Iodinated Aminosquaraines as Potential Sensitizers for Photodynamic Therapy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this work, several benzothiazole-based aminosquaraine dyes, displaying strong absorption within the so-called phototherapeutic window (650–800 nm), were synthesized. The ability, of all the new dyes, to generate singlet oxygen was assessed by determining the correspondent phosphorescence emission and through the comparison with a standard. The quantum yields of singlet oxygen generation were determined and exhibited to be strongly dependent on the nature of the amino substituents introduced in the squaric ring. The photodynamic activity of the synthesized dyes was tested against four human tumor cell lines: breast (MCF-7), lung (NCI-H460), cervical (HeLa) and hepatocellular (HepG2) carcinomas; and a non-tumor porcine liver primary cell culture (PLP2). All the compounds synthesized were found to be able to inhibit tumor cells growth upon irradiation more than in the dark, in most of the cases, very significantly. Considering the photodynamic activity exhibited and the low toxicity displayed for the non-tumor cells, some of the synthetized dyes can be regarded as potential candidates as photosensitizers for PDT.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Photodynamic therapy and anti-tumour immunity.

          Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

            Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a photochemical reaction between a light activatable molecule or photosensitizer, light, and molecular oxygen. When these three harmless components are present together, reactive oxygen species are formed. These can directly damage cells and/or vasculature, and induce inflammatory and immune responses. PDT is a two-stage procedure, which starts with photosensitizer administration followed by a locally directed light exposure, with the aim of confined tumor destruction. Since its regulatory approval, over 30 years ago, PDT has been the subject of numerous studies and has proven to be an effective form of cancer therapy. This review provides an overview of the clinical trials conducted over the last 10 years, illustrating how PDT is applied in the clinic today. Furthermore, examples from ongoing clinical trials and the most recent preclinical studies are presented, to show the directions, in which PDT is headed, in the near and distant future. Despite the clinical success reported, PDT is still currently underutilized in the clinic. We also discuss the factors that hamper the exploration of this effective therapy and what should be changed to render it a more effective and more widely available option for patients.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Definition of type I and type II photosensitized oxidation.

                Bookmark

                Author and article information

                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                28 February 2019
                March 2019
                : 24
                : 5
                : 863
                Affiliations
                [1 ]Centro de Química-Vila Real (CQ-VR), Universidade de Trás-os-Montes e Alto Douro, 5001-801 Vila Real, Portugal; filipamandim@ 123456ipb.pt (F.M.); vcssg_22@ 123456hotmail.com (V.C.G.)
                [2 ]Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal; calhelha@ 123456ipb.pt
                [3 ]CQFM-Centro de Química-Física Molecular and IN-Institute for Nanosciences and Nanotechnologies and IBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal; ilferreiramachado@ 123456tecnico.ulisboa.pt (I.L.F.M.); LuisFilipeVF@ 123456ist.utl.pt (L.F.V.F.)
                [4 ]Instituto Politécnico de Portalegre, P-7300-110 Portalegre, Portugal
                Author notes
                [* ]Correspondence: iferreira@ 123456ipb.pt (I.C.F.R.F.); psantos@ 123456utad.pt (P.F.S.); Tel.: +351-273-303-219 (I.C.F.R.F.); +351-259-350-321 (P.F.S.)
                Author information
                https://orcid.org/0000-0002-6494-2326
                https://orcid.org/0000-0002-6801-4578
                https://orcid.org/0000-0001-7527-9489
                https://orcid.org/0000-0002-1903-5815
                https://orcid.org/0000-0003-4910-4882
                https://orcid.org/0000-0002-8723-4373
                Article
                molecules-24-00863
                10.3390/molecules24050863
                6429055
                30823489
                ae07b292-119e-4c75-8c8d-d70c3098ad39
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 06 January 2019
                : 23 February 2019
                Categories
                Article

                squaraine,singlet oxygen,photodynamic therapy
                squaraine, singlet oxygen, photodynamic therapy

                Comments

                Comment on this article